Advertisement
BUD vs EDVA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BUD is a Hold and EDVA is a Hold.
BUD's RSI Indicator climbs out of oversold territory
The RSI Oscillator for BUD moved out of oversold territory on October 05, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 23 similar instances when the indicator left oversold territory. In 17 of the 23 cases the stock moved higher. This puts the odds of a move higher at 74%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on BUD as a result. In 40 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 51%.
The Moving Average Convergence Divergence (MACD) for BUD just turned positive on October 08, 2026. Looking at past instances where BUD's MACD turned positive, the stock continued to rise in 25 of 44 cases over the following month. The odds of a continued upward trend are 57%.
BUD moved above its 50-day moving average on October 13, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where BUD advanced for three days, in 185 of 332 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
BUD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BUD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.
The Aroon Indicator for BUD entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating for company is 32 (best 1 - 100 worst), which means the company is slightly undervalued. The valuation of the company is based on a proprietary formula which takes into account a set of fundamentals and gives us an estimate of the price per share for the company. We then compare this estimate with the current price per share. As a result, this company is rated as undervalued in the industry. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.624) is normal, around the industry mean (2.040). P/E Ratio (16.616) is within average values for comparable stocks, (16.716). Projected Growth (PEG Ratio) (1.583) is also within normal values, averaging (2.082). Dividend Yield (0.018) settles around the average of (0.034) among similar stocks. BUD's P/S Ratio (2.564) is slightly higher than the industry average of (1.539).
The Tickeron Profit vs. Risk Rating rating for this company is 38 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 39 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. BUD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
Momentum Indicator for EDVA turns negative, indicating new downward trend
EDVA saw its Momentum Indicator move below the 0 level on September 18, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 77 similar instances where the indicator turned negative. In 72 of the 77 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EDVA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for EDVA entered a downward trend on October 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for EDVA just turned positive on October 06, 2026. Looking at past instances where EDVA's MACD turned positive, the stock continued to rise in 37 of 39 cases over the following month. The odds of a continued upward trend are 90%.
Following a +5.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where EDVA advanced for three days, in 169 of 197 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
EDVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.154) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (10.695) is also within normal values, averaging (437.542).
The Tickeron Price Growth Rating for this company is 96 (best 1 - 100 worst), indicating slightly worse than average price growth. EDVA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EDVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
BUD | EDVA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 30 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 32 Undervalued | 6 Undervalued | |
PROFIT vs RISK RATING 1..100 | 38 | 100 | |
SMR RATING 1..100 | 68 | 100 | |
PRICE GROWTH RATING 1..100 | 45 | 96 | |
P/E GROWTH RATING 1..100 | 39 | 100 | |
SEASONALITY SCORE 1..100 | 85 | 26 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
EDVA's Valuation (6) in the null industry is in the same range as BUD (32) in the Beverages Alcoholic industry. This means that EDVA’s stock grew similarly to BUD’s over the last 12 months.
BUD's Profit vs Risk Rating (38) in the Beverages Alcoholic industry is somewhat better than the same rating for EDVA (100) in the null industry. This means that BUD’s stock grew somewhat faster than EDVA’s over the last 12 months.
BUD's SMR Rating (68) in the Beverages Alcoholic industry is in the same range as EDVA (100) in the null industry. This means that BUD’s stock grew similarly to EDVA’s over the last 12 months.
BUD's Price Growth Rating (45) in the Beverages Alcoholic industry is somewhat better than the same rating for EDVA (96) in the null industry. This means that BUD’s stock grew somewhat faster than EDVA’s over the last 12 months.
BUD's P/E Growth Rating (39) in the Beverages Alcoholic industry is somewhat better than the same rating for EDVA (100) in the null industry. This means that BUD’s stock grew somewhat faster than EDVA’s over the last 12 months.
| BUD | EDVA | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 74% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 57% | 1 day ago 87% |
| Momentum ODDS (%) | 1 day ago 51% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 57% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 55% | 1 day ago 90% |
| TrendMonth ODDS (%) | 1 day ago 52% | 1 day ago 90% |
| Advances ODDS (%) | 1 day ago 56% | 9 days ago 86% |
| Declines ODDS (%) | 14 days ago 50% | 1 day ago 90% |
| BollingerBands ODDS (%) | 1 day ago 65% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 48% | 1 day ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BUD’s FA Score shows that 1 FA rating(s) are green while EDVA’s FA Score has 1 green FA rating(s).
- BUD’s FA Score: 1 green, 4 red.
- EDVA’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BUD’s TA Score shows that 6 TA indicator(s) are bullish while EDVA’s TA Score has 5 bullish TA indicator(s).
- BUD’s TA Score: 6 bullish, 3 bearish.
- EDVA’s TA Score: 5 bullish, 3 bearish.
Price Growth
BUD (@Food: Meat/Fish/Dairy) experienced а +6.54% price change this week, while EDVA (@Biotechnology) price change was -15.09% for the same time period.
The average weekly price growth across all stocks in the @Food: Meat/Fish/Dairy industry was +4.10%. For the same industry, the average monthly price growth was +0.67%, and the average quarterly price growth was -7.55%.
The average weekly price growth across all stocks in the @Biotechnology industry was -8.52%. For the same industry, the average monthly price growth was -19.04%, and the average quarterly price growth was -19.99%.
Reported Earning Dates
BUD is expected to report earnings on Oct 29, 2026.
Industries' Descriptions
@Food: Meat/Fish/Dairy (+4.10% weekly)The meat, fish, and dairy food industry processes livestock, fish and milk products for consumer consumption. Some companies also process dairy byproducts. Tyson Foods, Inc., Hormel Foods Corporation and Pilgrims Pride Corp. are some of the biggest producers in this industry. Many of these companies are recipients of American farm subsidies. On the other hand, new-age food innovation like plant-based meat substitutes (which are designed to simulate chicken, beef, and pork sausage) could potentially augur disruptions and/or create new competition in this space.
@Biotechnology (-8.52% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
EDVA and
Correlation & Price change
A.I.dvisor tells us that EDVA and GPCR have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EDVA and GPCR's prices will move in lockstep.
| Ticker / NAME | Correlation To EDVA | 1D Price Change % | ||
|---|---|---|---|---|
| EDVA | 100% | -0.92% | ||
| GPCR - EDVA | 24% Poorly correlated | -1.93% | ||
| DEO - EDVA | 23% Poorly correlated | +1.74% | ||
| BUD - EDVA | 21% Poorly correlated | +1.12% | ||
| EXOZ - EDVA | 21% Poorly correlated | +0.22% | ||
| STZ - EDVA | 21% Poorly correlated | +0.28% | ||
More | ||||